Budesonide/Procaterol

布地奈德/丙卡特罗

Report date: 2025/11/27 15:17:49

Base Information

Drug NameBudesonide/Procaterol
Drug Alias Name丙卡特罗+布地奈德Procaterol+budesonide丙卡特罗/布地奈德Procaterol/budesonideBudesonide+Procaterol +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsYes Procaterol HydrochlorideBudesonide
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntech Biopharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntech Biopharm Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A